纤维蛋白原与COPD患者心血管或肌肉表现无关:ERICA研究横断面数据
本研究基于ERICA研究729例稳定期GOLD II-IV级COPD患者,测量主动脉脉搏波传导速度(aPWV)、股四头肌最大随意收缩力(QMVC)和纤维蛋白原。结果显示心血管与肌肉表现独立存在(P=0.22),纤维蛋白原与aPWV和QMVC均无关联(P=0.628和P=0.621),提示血浆纤维蛋白原所反映的炎症不太可能是共同病因。
要点
- COPD患者中心血管与肌肉表现独立存在,不互为关联。
- 血浆纤维蛋白原与主动脉僵硬度和股四头肌力量均无显著关联。
- 纤维蛋白原所代表的系统性炎症不太可能是心血管与肌肉表现的共同病因。
核心结论
- 在稳定期GOLD II-IV级COPD患者中,心血管与肌肉表现独立存在,纤维蛋白原与二者均无关联。
研究设计与样本
- ERICA研究的横断面分析,纳入729例稳定期GOLD II-IV级COPD患者。
主要发现
- 心血管与肌肉表现独立存在(P=0.22,χ2检验)。
- 纤维蛋白原与aPWV无关联(P=0.628)。
- 纤维蛋白原与QMVC无关联(P=0.621)。
临床怎么用
- 临床评估COPD心血管和肌肉合并症时应分别关注,不宜以纤维蛋白原作为共同炎症标志物进行统一筛查。
局限性
- 横断面设计无法推断因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiovascular and skeletal muscle manifestations constitute important comorbidities in COPD, with systemic inflammation proposed as a common mechanistic link. Fibrinogen has prognostic role in COPD. We aimed to determine whether aortic stiffness and quadriceps weakness are linked in COPD, and whether they are associated with the systemic inflammatory mediator-fibrinogen. Aortic pulse wave velocity (aPWV), quadriceps maximal volitional contraction (QMVC) force and fibrinogen were measured in 729 patients with stable, Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages II-IV COPD. The cardiovascular and muscular manifestations exist independently (P=0.22, χ2). Fibrinogen was not associated with aPWV or QMVC (P=0.628 and P=0.621, respectively), making inflammation, as measured by plasma fibrinogen, an unlikely common aetiological factor.
引用
- Mohan D, Forman JR, Allinder M, et al. Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study. Thorax. 2018. PMID: 29618495. doi:10.1136/thoraxjnl-2018-211556
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。